CSCO 2020 Look: What's the busiest PI, do you know?

As the saying goes, where there are people, there are rivers and lakes.
in medicine, even more so.
excellent clinical researchers (PI) in the pharmaceutical enterprises, as long as the drought meets Ganyu, other countries know.
people say that in the study of the project is the same, interesting PI million to choose one.
who have heard the tumor PI speech, no one is convinced by Wu Yilong's style, Li Jin's style, Lu Wei's wit, Shen Lin's style... It has also been joked that in China, there are no failed clinical trials, only the PI big man.
if your clinical research program has been approved by the cancer community's Nanshan Beidou, congratulations: the product may have half a foot into the door of CDE.
PI is so important, how do you find the right PI for your project? In the case of the Oncology Drug Project, watching CSCO may be a pretty good way to go.
the 2019 CSCO Conference, the organizing committee made a request that each PI platform satellite will not exceed six.
in the "first come, first 7" principle, the competition is also between the companies and the big man's personal relationship.
a little curious, when the 2020 CSCO satellite conference schedule was announced, the small editor pressed Tussauds to find out the busiest 20 PIs in CSCO this year.
as shown in the table, Wu Yilong, Shen Lin and Zhou Caixuan are the busiest PI of the current CSCO, all of which need to visit 10 satellite meetings.
Wu Yilong, a professor of surgery, is recognized as a "general talent" in the oncology community.
as director of the Guangdong Lung Cancer Research Institute, exploratory research has become the main direction of Wu Yilong, who is responsible for the world's leading new cancer drug clinical trials in China, the hands of various clinical trials code-named Chinese patients with advanced cancer hope.
Wu Yilong, a professor of cancer, has said in public that making lung cancer a real chronic disease is his lifelong dream and goal.
it is worth mentioning that Professor Wu Yilong is at the top of the list of the top 100 academic influence of lung cancer experts in China.
In the field of oncology in China, gastric cancer experts have "North Shen, South Li" Ya, "North Shen" refers to Professor Shen Lin of Peking University Cancer Hospital, "South Li" refers to The Shanghai Oriental Hospital well-known oncologist, former chairman of CSCO Professor Li Jin.
In the male-dominated hospital management field, Professor Shen Lin is one of the few goddesses with professional and management skills, who not only leads the academic development of digestive oncology in China, but also serves as vice president of Peking University Oncology Hospital and is also an advocate of multidisciplinary consultation mode (MDT).
Jianghu called Professor Shen Lin "Aunt Shen", although she deals with death every day, but love to dance hip-hop, positive and optimistic attitude so that many of the same action.
she has encouraged innovative pharmaceutical companies to conduct more research on translational medicine technology to bring more affordable cancer-based drugs to patients.
industry often take lung cancer as the "mountain" of tumors, there are "lung cancer patients get the world" said.
as director of oncology department of Shanghai Lung Hospital and director of lung cancer immunology research office, Professor Zhou Caisan is the "immune therapy for the first line of lung cancer" strong.
, he said, "Since immunotherapy, we lung cancer experts are confident that we can fulfill the task entrusted to us by the government to increase the five-year survival rate of cancer to 43.3 percent."
In addition to the above three PI, the oncology community also has a lot of big guys are busy, such as humorous Professor Li Jin has undertaken more than 100 clinical studies, China's melanoma discipline leader, known as "black boss" Professor Guo Jun led clinical trials also have more than 60.
to appreciate the different styles of the above PI, let's meet CSCO.
source: Medical Rubik's Cube Med Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Met Medical" or "Source: MedSci Original" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and must be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
reproduce content at the same time does not represent the position of this site.
leave a message here.